Korean Circulation Journal

  • 제46권4호
  • /
  • Pages.456-467
  • /
  • 2016
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Systemic Hemodynamic Atherothrombotic Syndrome and Resonance Hypothesis of Blood Pressure Variability: Triggering Cardiovascular Events

  • Kario, Kazuomi (Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine)
  • 투고 : 2016.03.15
  • 심사 : 2016.05.27
  • 발행 : 2016.07.30
⟨ 이전 논문 다음 논문 ⟩

초록

Blood pressure (BP) exhibits different variabilities and surges with different time phases, from the shortest beat-by-beat to longest yearly changes. We hypothesized that the synergistic resonance of these BP variabilites generates an extraordinarily large dynamic surge in BP and triggers cardiovascular events (the resonance hypothesis). The power of pulses is transmitted to the peripheral sites without attenuation by the large arteries, in individuals with stiffened arteries. Thus, the effect of a BP surge on cardiovascular risk would be especially exaggerated in high-risk patients with vascular disease. Based on this concept, our group recently proposed a new theory of systemic hemodynamic atherothromboltic syndrome (SHATS), a vicious cycle of hemodynamic stress and vascular disease that advances organ damage and triggers cardiovascular disease. Clinical phenotypes of SHATS are large-artery atherothombotic diseases such as stroke, coronary artery disease, and aortic and pheripheral artery disease; small-artery diseases, and microcirculation-related disease such as vascular cognitive dysfunction, heart failure, and chronic kidney disease. The careful consideration of BP variability and vascular diseases such as SHATS, and the early detection and management of SHATS, will achieve more effective individualized cardiovascular protection. In the near future, information and communication technology-based 'anticipation medicine' predicted by the changes of individual BP values could be a promising approach to achieving zero cardiovascular events.

키워드

참고문헌

  1. Lawes CM, Bennett DA, Parag V, et al; Asia Pacific Cohort Studies Collaboration. Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis. Hypertension 2003;42:69-75. https://doi.org/10.1161/01.HYP.0000075083.04415.4B
  2. Ueshima H, Sekikawa A, Miura K, et al. Cardiovascular disease and risk factors in Asia: a selected review. Circulation 2008;118:2702-9. https://doi.org/10.1161/CIRCULATIONAHA.108.790048
  3. Hoshide S, Wang J, Park SH, et al. Treatment considerations of clinical physician on hypertension management in Asia. Curr Hypertens Rev 2016;12:164-8. https://doi.org/10.2174/1573402111666150812143155
  4. Park JB, Kario K, Wang JG. Systolic hypertension: an increasing clinical challenge in Asia. Hypertens Res 2015;38:227-36. https://doi.org/10.1038/hr.2014.169
  5. Shimamoto K, Ando K, Fujita T, et al; Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res 2014;37:253-390. https://doi.org/10.1038/hr.2014.20
  6. Kario K. Essential manual of 24-hour blood pressure management from morning to nocturnal hypertension. London, UK; Wiley-Blackwell; 2015. p. 1-138.
  7. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 2006;354:2368-74. https://doi.org/10.1056/NEJMra060433
  8. O'Brien E, Parati G, Stergiou G, et al; European Society of Hypertension Working Group on Blood Pressure Monitoring. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013;31:1731-68. https://doi.org/10.1097/HJH.0b013e328363e964
  9. Imai Y, Ohkubo T, Sakuma M, et al. Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan. Blood Press Monit 1996;1:251-4.
  10. Kario K, Shimada K, Schwartz JE, Matsuo T, Hoshide S, Pickering TG. Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol 2001;38:238-45. https://doi.org/10.1016/S0735-1097(01)01325-0
  11. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 2003; 107:1401-6. https://doi.org/10.1161/01.CIR.0000056521.67546.AA
  12. Clement DL, De Buyzere ML, De Bacquer DA, et al; Office versus Ambulatory Pressure Study Investigators. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003;348:2407-15. https://doi.org/10.1056/NEJMoa022273
  13. Ohkubo T, Kikuya M, Metoki H, et al. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005;46:508-15. https://doi.org/10.1016/j.jacc.2005.03.070
  14. Kario K, Okura A, Okawara Y, Tomitani N, Ikemoto T, Hoshide S. Impact of introducing catheter-based renal denervation into Japan for hypertension management: Estimation of number of target patients and clinical relevance of ambulatory blood pressure reduction. Cur Hypertens Rev 2016;12:156-63. https://doi.org/10.2174/1573402112666160302102841
  15. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol 2013;10:143-55. https://doi.org/10.1038/nrcardio.2013.1
  16. Kario K. Prognosis in relation to blood pressure variability: Pro side of the argument. Hypertension 2015;65:1163-9. https://doi.org/10.1161/HYPERTENSIONAHA.115.04800
  17. Kario K. New insight of morning blood pressure surge into the triggers of cardiovascular disease-synergistic resonance of blood pressure variability. Am J Hypertens 2016; 29:14-6. https://doi.org/10.1093/ajh/hpv114
  18. Kario K. Orthostatic hypertension-a new haemodynamic cardiovascular risk factor. Nat Rev Nephrol 2013;9:726-38. https://doi.org/10.1038/nrneph.2013.224
  19. Kario K. Proposal of a new strategy for ambulatory blood pressure profile-based management of resistant hypertension in the era of renal denervation. Hypertens Res 2013;36:478-84. https://doi.org/10.1038/hr.2013.19
  20. Kario K. Systemic hemodynamic atherothrombotic syndrome: a blind spot in the current management of hypertension. J Clin Hypertens (Greenwich) 2015;17:328-31. https://doi.org/10.1111/jch.12505
  21. Kario K. Morning surge in blood pressure: a phenotype of systemic hemodynamic atherothrombotic syndrome. Am J Hypertens 2015;28:7-9. https://doi.org/10.1093/ajh/hpu179
  22. Kario K, Hamasaki H. Nocturnal Blood Pressure Surge Behind Morning Surge in Obstructive Sleep apnea syndrome: another phenotype of systemic hemodynamic atherothrombotic syndrome. J Clin Hypertens (Greenwich) 2015;17:682-5. https://doi.org/10.1111/jch.12576
  23. Kikuya M, Ohkubo T, Metoki H, et al. Day by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension 2008;52:1045-50. https://doi.org/10.1161/HYPERTENSIONAHA.107.104620
  24. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375:895-905. https://doi.org/10.1016/S0140-6736(10)60308-X
  25. Matsui Y, Ishikawa J, Eguchi K, Shibasaki S, Shimada K, Kario K. Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension. Hypertension 2011;57:1087-93. https://doi.org/10.1161/HYPERTENSIONAHA.111.171645
  26. Muntner P, Shimbo D, Tonelli M, Reynolds K, Arnett DK, Oparil S. The relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population: findings from NHANES III, 1988 to 1994. Hypertension 2011;57:160-6. https://doi.org/10.1161/HYPERTENSIONAHA.110.162255
  27. Matsui Y, O'Rourke MF, Hoshide S, Ishikawa J, Shimada K, Kario K. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension 2012;59:1132-8. https://doi.org/10.1161/HYPERTENSIONAHA.111.189217
  28. Eguchi K, Hoshide S, Schwartz JE, Shimada K, Kario K. Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens 2012;25:962-8. https://doi.org/10.1038/ajh.2012.75
  29. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: new independent determinants for cognitive function in the elderly at high risk of cardiovascular disease. J Hypertens 2012;30:1556-63. https://doi.org/10.1097/HJH.0b013e3283552735
  30. Nagai M, Hoshide S, Nishikawa M, Shimada K, Kario K. Sleep duration and insomnia in the elderly: associations with blood pressure variability and carotid artery remodeling. Am J Hypertens 2013;26:981-9. https://doi.org/10.1093/ajh/hpt070
  31. Nagai M, Kario K. Visit-to-visit blood pressure variability, silent cerebral injury, and risk of stroke. Am J Hypertens 2013;26:1369-76. https://doi.org/10.1093/ajh/hpt167
  32. Yokota K, Fukuda M, Matsui Y, Hoshide S, Shimada K, Kario K. Impact of visit-to-visit variability of blood pressure on deterioration of renal function in patients with non-diabetic chronic kidney disease. Hypertens Res 2013;36:151-7. https://doi.org/10.1038/hr.2012.145
  33. Kawai T, Ohishi M, Ito N, et al. Alteration of vascular function is an important factor in the correlation between visit-to-visit blood pressure variability and cardiovascular disease. J Hypertens 2013;31:1387-95. https://doi.org/10.1097/HJH.0b013e328360f796
  34. Kawai T, Ohishi M, Kamide K, et al. Differences between daytime and nighttime blood pressure variability regarding systemic atherosclerotic change and renal function. Hypertens Res 2013;36:232-9. https://doi.org/10.1038/hr.2012.162
  35. Fukui M, Ushigome E, Tanaka M, et al. Home blood pressure variability on one occasion is a novel factor associated with arterial stiffness in patients with type 2 diabetes. Hypertens Res 2013;36:219-25. https://doi.org/10.1038/hr.2012.177
  36. Endo K, Kario K, Koga M, et al. Impact of early blood pressure variability on stroke outcomes after thrombolysis: the SAMURAI rt-PA Registry. Stroke 2013;44:816-8. https://doi.org/10.1161/STROKEAHA.112.681007
  37. Tanaka E, Koga M, Kobayashi J, et al. Blood pressure variability on antihypertensive therapy in acute intracerebral hemorrhage: the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-intracerebral hemorrhage study. Stroke 2014;45:2275-9. https://doi.org/10.1161/STROKEAHA.114.005420
  38. Wei FF, Li Y, Zhang L, et al. Beat-to-beat, reading-to-reading, and day-to-day blood pressure variability in relation to organ damage in untreated Chinese. Hypertension 2014;63:790-6. https://doi.org/10.1161/HYPERTENSIONAHA.113.02681
  39. Nagai M, Hoshide S, Nishikawa M, Masahisa S, Kario K. Visit-to-visit blood pressure variability in the elderly: associations with cognitive impairment and carotid artery remodeling. Atherosclerosis 2014;233:19-26. https://doi.org/10.1016/j.atherosclerosis.2013.11.071
  40. Palatini P, Reboldi G, Beilin LJ, et al. Added predictive value of night-time blood pressure variability for cardiovascular events and mortality: the Ambulatory Blood Pressure-International Study. Hypertension 2014;64:487-93. https://doi.org/10.1161/HYPERTENSIONAHA.114.03694
  41. Kagitani H, Hoshide S, Kario K. Optimal indicators of home BP variability in perimenopausal women and associations with albuminuria and reproducibility: The J-HOT home BP study. Am J Hypertens 2015;28:586-94. https://doi.org/10.1093/ajh/hpu210
  42. Rakugi H, Ogihara T, Saruta T, et al; COLM Investigators. Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis. J Hypertens 2015;33:2165-72. https://doi.org/10.1097/HJH.0000000000000668
  43. Shibasaki S, Hoshide S, Eguchi K, Ishikawa J, Kario K; Japan Morning Surge-Home Blood Pressure (J-HOP) Study Group. Increase trend in home blood pressure on a single occasion is associated With B-type natriuretic peptide and the estimated glomerular filtration rate. Am J Hypertens 2015;28:1098-105. https://doi.org/10.1093/ajh/hpu295
  44. Liu Z, Zhao Y, Zhang H, et al. Excessive variability in systolic blood pressure that is self-measured at home exacerbates the progression of brain white matter lesions and cognitive impairment in the oldest old. Hypertens Res 2016;39:245-53. https://doi.org/10.1038/hr.2015.135
  45. Kario K, Tomitani N, Matsumoto Y, et al. Research and development of information and communication technology-based home blood pressure monitoring from morning to nocturnal hypertension. Ann Glob Health 2016;82:254-73. https://doi.org/10.1016/j.aogh.2016.02.004
  46. Kario K, Eguchi K, Nakagawa Y, Motai K, Shimada K. Relationship between extreme dippers and orthostatic hypertension in elderly hypertensive patients. Hypertension 1998;31:77-82. https://doi.org/10.1161/01.HYP.31.1.77
  47. Kario K, Eguchi K, Hoshide S, et al. U-curve relationship between orthostatic blood pressure change and silent cerebrovascular disease in elderly hypertensives: orthostatic hypertension as a new cardiovascular risk factor. J Am Coll Cardiol 2002;40:133-41. https://doi.org/10.1016/S0735-1097(02)01923-X
  48. Kario K. Orthostatic hypertension: a measure of blood pressure variation for predicting cardiovascular risk. Circ J 2009;73:1002-7. https://doi.org/10.1253/circj.CJ-09-0286
  49. Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res 2009;32:115-21. https://doi.org/10.1038/hr.2008.27
  50. Metoki H , Ohkubo T , Kikuya M , Asayama K , Obara T , Hashimoto J , Totsune K , Hoshi H , Satoh H , Imai Y . Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 2006;47:149-54 . https://doi.org/10.1161/01.HYP.0000198541.12640.0f
  51. Nakase T, Yoshioka S, Sasaki M, Suzuki A. Clinical evaluation of lacunar infarction and branch atheromatous disease . J Stroke Cerebrovasc Dis 2013;22:406-12. https://doi.org/10.1016/j.jstrokecerebrovasdis.2011.10.005
  52. Kario K, Pickering TG. Blood pressure variability in elderly patients. Lancet 2000;355:1645-6.
  53. Matsui Y, Eguchi K, Shibasaki S, et al; Japan morning Surge‐1 Study Group. Impact of arterial stiffness reduction on urinary albumin excretion during antihypertensive treatment: the Japan morning Surge‐1 study. J Hypertens 2010;28:1752-60. https://doi.org/10.1097/HJH.0b013e32833a3981
  54. Kario K. Morning surge in blood pressure and cardiovascular risk – evidence and perspectives. Hypertension 2010;56:765-73. https://doi.org/10.1161/HYPERTENSIONAHA.110.157149
  55. Li Y, Thijs L, Hansen TW, et al; International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Investigators. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension 2010;55:1040-8. https://doi.org/10.1161/HYPERTENSIONAHA.109.137273
  56. Luo Y, Wang YL, Wu YB, et al. Association between the rate of the morning surge in blood pressure and cardiovascular events and stroke. Chin Med J (Engl) 2013;126:510-4.
  57. Verdecchia P, Angeli F, Mazzotta G, et al. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension 2012;60:34-42. https://doi.org/10.1161/HYPERTENSIONAHA.112.191858
  58. Bombelli M, Fodri D, Toso E, et al. Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population. Hypertension 2014;64:943-50. https://doi.org/10.1161/HYPERTENSIONAHA.114.03675
  59. Hoshide S, Kario K, de la Sierra A, et al. Ethnic differences in the degree of morning blood pressure surge and in its determinants between Japanese and European hypertensive subjects: data from the ARTEMIS study. Hypertension 2015;66:750-6. https://doi.org/10.1161/HYPERTENSIONAHA.115.05958
  60. Kario K. Caution for winter morning surge in blood pressure: a possible link with cardiovascular risk in the elderly. Hypertension 2006;47:139-40. https://doi.org/10.1161/01.HYP.0000199162.89857.7a
  61. Murakami S, Otsuka K, Kubo Y, et al. Repeated ambulatory monitoring reveals a Monday morning surge in blood pressure in a community-dwelling population. Am J Hypertens 2004;17:1179-83. https://doi.org/10.1016/j.amjhyper.2004.07.016
  62. Kario K. Clinician's manual on early morning risk management in hypertension. London, UK; Science Press; 2004. p.1-68.
  63. Kario K, Ishikawa J, Pickering TG, et al. Morning hypertension: the strongest independent risk factor for stroke in elderly hypertensive patients. Hypertens Res 2006;29:581-7. https://doi.org/10.1291/hypres.29.581
  64. Kario K, Eguchi K, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: response. Circulation 2003;108:e72-3. https://doi.org/10.1161/01.CIR.0000089096.13946.CB
  65. Hoshide S, Kario K, Yano Y, et al; J‐HOP study group. Association of morning and evening blood pressure at home with asymptomatic organ damage in the J-HOP Study. Am J Hypertens 2014;27:939-47. https://doi.org/10.1093/ajh/hpt290
  66. Kario K, Saito I, Kushiro T, et al. Home blood pressure and cardiovascular outcomes in patients during antihypertensive therapy: primary results of HONEST, a large‐scale prospective, real‐world observational study. Hypertension 2014;64:989-96. https://doi.org/10.1161/HYPERTENSIONAHA.114.04262
  67. Kario K. Benefits of strict blood-pressure lowering in hypertension. Nat Rev Cardiol 2016;13:125-6. https://doi.org/10.1038/nrcardio.2016.13
  68. Kario K, Saito I, Kushiro T, et al. Morning home blood pressure is a strong predictor of coronary artery disease. J Am Coll Cardiol 2016;67:1519-27.
  69. Panza JA, Epstein SE, Quyyumi AA. Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med 1991;325:986-90. https://doi.org/10.1056/NEJM199110033251402
  70. Kario K, Pickering TG, Hoshide S, et al. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system. Am J Hypertens 2004;17:668-75. https://doi.org/10.1016/j.amjhyper.2004.04.001
  71. Kario K, Matsui Y, Shibasaki S, et al.; Japan Morning Surge-1 (JMS-1) Study Group. An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study. J Hypertens 2008;26:1257-65. https://doi.org/10.1097/HJH.0b013e3282fd173c
  72. Krum H, Schlaich MP, Sobotka PA, et al. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 2014;383:622-9. https://doi.org/10.1016/S0140-6736(13)62192-3
  73. Esler MD, Krum H, Schlaich M et al; Symplicity HTN-2 Investigators. Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial. Circulation 2012;126:2976-82. https://doi.org/10.1161/CIRCULATIONAHA.112.130880
  74. Hering D, Lambert EA, Marusic P, et al. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension 2013;61:457-64. https://doi.org/10.1161/HYPERTENSIONAHA.111.00194
  75. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009;361:932-4. https://doi.org/10.1056/NEJMc0904179
  76. Kario K, Ogawa H, Okumura K, et al; SYMPLICITY HTN-Japan Investigators. SYMPLICITY HTN-Japan-first randomized controlled trial of catheterbased renal denervation in Asian patients. Circ J 2015;79:1222-9. https://doi.org/10.1253/circj.CJ-15-0150
  77. Bhatt DL, Kandzari DE, O'Neill WW, et al; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014;370:1393-401. https://doi.org/10.1056/NEJMoa1402670
  78. Kario K, Bhatt DL, Brar S, Cohen SA, Fahy M, Bakris GL. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan. Hypertension 2015;66:1130-7.
  79. Kario K. Obstructive sleep apnea syndrome and hypertension: ambulatory blood pressure. Hypertens Res 2009;32:428-32. https://doi.org/10.1038/hr.2009.56
  80. Shirasaki O, Kuwabara M, Saito M, Tagami K, Washiya S, Kario K. Development and clinical application of a new technique for detecting ‘sleep blood pressure surges' in sleep apnea patients based on a variable desaturation threshold. Hypertens Res 2011;34:922-8. https://doi.org/10.1038/hr.2011.52
  81. Kario K, Kuwabara M, Hoshide S, Nagai M, Shimpo M. Effects of nighttime single-dose administration of vasodilating vs. sympatholytic antihypertensive agents on sleep blood pressure in hypertensive patients with sleep apnea syndrome. J Clin Hypertens 2014;16:459-66. https://doi.org/10.1111/jch.12327
  82. Kuwabara M, Kario K. Development of a triggered nocturnal blood pressure monitoring which detects nighttime blood pressure surges in sleep apnea syndrome. Curr Hypertens Rev 2016;12:27-31. https://doi.org/10.2174/1573402112666160114093500
  83. Yoshida T, Kuwabara M, Hoshide S, Kario K. Recurrence of stroke caused by nocturnal hypoxia-induced blood pressure surge in a young adult male with severe obstructive sleep apnea syndrome. J Am Soc Hypertens 2016;10:201-4. https://doi.org/10.1016/j.jash.2016.01.013
  84. Kario K, Ikemoto T, Kuwabara M, Ishiyama H, Saito K, Hoshide S. Catheter-based renal denervation reduces hypoxia-triggered nocturnal blood pressure peak in obstructive sleep apnea syndrome. J Clin Hypertens (Greenwich) 2015. [in press]
  85. Kario K, Bhatt DL, Kandzari DE, et al. Impact of renal denervation on patients with obstructive sleep apnea and resistant hypertension: insights from the SYMPLICITY HTN-3 trial. Circ J 2016;80:1404-12. https://doi.org/10.1253/circj.CJ-16-0035
  86. Kim BK, Böhm M, Mahfoud F, et al. Renal denervation for treatment of uncontrolled hypertension in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea). J Hum Hypertens 2016;30:315-21. https://doi.org/10.1038/jhh.2015.77
  87. Kandzari D, Kario K, Mahfoud F, et al. The SPYRAL HTN global clinical trial program: rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications. Am Heart J 2016;171;82-91. https://doi.org/10.1016/j.ahj.2015.08.021

피인용 문헌

  1. Relation of blood pressure variability to left ventricular function and arterial stiffness in hypertensive patients vol.60, pp.8, 2016, https://doi.org/10.11622/smedj.2019030
  2. Systemic hemodynamic atherothrombotic syndrome in the young: An early phenotype of established cardiovascular disease? vol.7, pp.2, 2021, https://doi.org/10.4103/jpcs.jpcs_44_21
  3. Association Between Morning Surge in Systolic Blood Pressure and SYNTAX Score I in Patients With Stable Coronary Artery Disease vol.48, pp.2, 2021, https://doi.org/10.14503/thij-19-7092
  4. Reader Response: Association of Time of Day When Endovascular Therapy for Stroke Starts and Functional Outcome vol.97, pp.12, 2021, https://doi.org/10.1212/wnl.0000000000012582
  5. Author Response: Association of Time of Day When Endovascular Therapy for Stroke Starts and Functional Outcome vol.97, pp.12, 2016, https://doi.org/10.1212/wnl.0000000000012583